MASTERINVEST Kapitalanlage GmbH Purchases New Position in Danaher Corporation $DHR

Key Points

• MASTERINVEST Kapitalanlage GmbH purchased 14,233 Danaher shares in the second quarter, valued at approximately $2.71 million. Institutional investors collectively own 79.05% of the company.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $228.91, although several firms recently lowered targets or ratings.
• Danaher exceeded quarterly expectations, reporting $1.94 in earnings per share versus the $1.85 consensus and revenue of $6.26 billion, up 5.5% year over year.

MASTERINVEST Kapitalanlage GmbH purchased a new position in Danaher Corporation (NYSE:DHR - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 14,233 shares of the conglomerate's stock, valued at approximately $2,711,000.

Other hedge funds also recently bought and sold shares of the company. Main Street Group LTD purchased a new stake in shares of Danaher in the first quarter valued at approximately $25,000. N.E.W. Advisory Services LLC purchased a new position in shares of Danaher during the 2nd quarter valued at approximately $25,000. JPL Wealth Management LLC acquired a new stake in Danaher in the 3rd quarter valued at $25,000. WFA of San Diego LLC purchased a new stake in Danaher in the 2nd quarter worth $26,000. Finally, Hilton Head Capital Partners LLC acquired a new position in Danaher during the fourth quarter worth $27,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on DHR shares. HSBC dropped their target price on shares of Danaher from $270.00 to $230.00 and set a "buy" rating on the stock in a research report on Wednesday, June 3rd. Weiss Ratings raised shares of Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Wednesday, July 15th. Wells Fargo & Company lowered their price objective on Danaher from $212.00 to $195.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 22nd. TD Cowen reduced their target price on Danaher from $240.00 to $236.00 and set a "buy" rating for the company in a report on Wednesday, July 22nd. Finally, Wolfe Research downgraded Danaher from an "outperform" rating to a "peer perform" rating in a research report on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Danaher has a consensus rating of "Moderate Buy" and an average price target of $228.91.

Danaher Stock Up 0.2%

NYSE DHR opened at $215.74 on Friday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The business's fifty day simple moving average is $198.69 and its 200-day simple moving average is $192.35. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The firm has a market cap of $151.67 billion, a PE ratio of 38.32, a P/E/G ratio of 2.68 and a beta of 0.78.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion during the quarter, compared to analysts' expectations of $6.12 billion. During the same quarter in the prior year, the company posted $0.77 EPS. The business's revenue for the quarter was up 5.5% on a year-over-year basis. As a group, equities analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.